Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

NCT00494338 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped due to celecoxib safety issues

Conditions

Interventions

Sponsor

Sanofi